AbbVie’s OnabotulinumtoxinA is Up as a Potential Treatment for Plastyma Prominence

Botulinum toxin type A (onabotulinumtoxinA or ONA) proved to be a safe and effective treatment for facial lines and wrinkles. Now, AbbVie, the company behind the popular injectable brand, revealed that the treatment has achieved positive topline results for the treatment of platysma prominence, a sign of aging that disrupts the neck, jawline, and lower face.
read more..